⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RXRX News
Recursion Pharmaceuticals, Inc. Class A Common Stock
In Silico Clinical Trials Research Report 2026: $6.14 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
RXRX
EVTC
Europe and the USA Patent Protection for Software-Related Inventions Course (ONLINE EVENT: May 13, 2026)
globenewswire.com
RXRX
Recursion to Participate in Upcoming Investor Conferences
globenewswire.com
RXRX
Cell Therapy Market Size to Surpass USD 17.15 Billion by 2032, Driven by Chronic Disease Treatment and CAR-T Therapy Growth, Says New MMR Analysis
prnewswire.com
GILD
JNJ
BMY
REGN
VERI
RXRX
MAGN
ALLO
Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
globenewswire.com
RXRX
Form 8-K
sec.gov
RXRX
Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
globenewswire.com
RXRX
EXEL
MRK
BMY
GSK
Nvidia’s Bet on Digital Biology and Stocks That Could Ride the Wave
globenewswire.com
RXRX
TEM
NVDA
PacBio Announces the Appointment of Chris Gibson to the Board of Directors
globenewswire.com
PACB
RXRX
AI Biotech, APAC Expansion, and Balance Sheet Rebuilds Set the Morning Tone
globenewswire.com
XWEL
RXRX
NXPL